These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29176472)

  • 1. Omes of Inflammatory Bowel Disease: A Primer for Clinicians.
    Picoraro JA; LeLeiko NS
    J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):374-377. PubMed ID: 29176472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenome-metabolome-microbiome axis in health and IBD.
    Amatullah H; Jeffrey KL
    Curr Opin Microbiol; 2020 Aug; 56():97-108. PubMed ID: 32920333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-omics in Inflammatory Bowel Disease Research: Applications, Challenges, and Guidelines.
    Valles-Colomer M; Darzi Y; Vieira-Silva S; Falony G; Raes J; Joossens M
    J Crohns Colitis; 2016 Jun; 10(6):735-46. PubMed ID: 26802086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy.
    de Souza HSP; Fiocchi C; Iliopoulos D
    Nat Rev Gastroenterol Hepatol; 2017 Dec; 14(12):739-749. PubMed ID: 28831186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics and metabolomics in inflammatory bowel disease.
    Yau Y; Leong RW; Zeng M; Wasinger VC
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1076-86. PubMed ID: 23489082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Involvement of Intestinal Tryptophan Metabolism in Inflammatory Bowel Disease Identified by a Meta-Analysis of the Transcriptome and a Systematic Review of the Metabolome.
    Wang S; van Schooten FJ; Jin H; Jonkers D; Godschalk R
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
    Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism.
    Moco S; Candela M; Chuang E; Draper C; Cominetti O; Montoliu I; Barron D; Kussmann M; Brigidi P; Gionchetti P; Martin FP
    Inflamm Bowel Dis; 2014 Nov; 20(11):2104-14. PubMed ID: 25029616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.
    Titz B; Gadaleta RM; Lo Sasso G; Elamin A; Ekroos K; Ivanov NV; Peitsch MC; Hoeng J
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Metaproteomics and Activity-Based Probe Enrichment Reveals Significant Alterations in Protein Expression from a Mouse Model of Inflammatory Bowel Disease.
    Mayers MD; Moon C; Stupp GS; Su AI; Wolan DW
    J Proteome Res; 2017 Feb; 16(2):1014-1026. PubMed ID: 28052195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes and 'in-vironment': how will our concepts on the pathophysiology of inflammatory bowel disease develop in the future?
    Fiocchi C
    Dig Dis; 2012; 30 Suppl 3():2-11. PubMed ID: 23295686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases.
    Fofanova TY; Petrosino JF; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):208-19. PubMed ID: 26308318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-environment interactions in inflammatory bowel disease pathogenesis.
    Wang MH; Achkar JP
    Curr Opin Gastroenterol; 2015 Jul; 31(4):277-82. PubMed ID: 26039718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gut Microbiome, Its Metabolome, and Their Relationship to Health and Disease.
    Wu GD
    Nestle Nutr Inst Workshop Ser; 2016; 84():103-10. PubMed ID: 26764479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease.
    Häsler R; Sheibani-Tezerji R; Sinha A; Barann M; Rehman A; Esser D; Aden K; Knecht C; Brandt B; Nikolaus S; Schäuble S; Kaleta C; Franke A; Fretter C; Müller W; Hütt MT; Krawczak M; Schreiber S; Rosenstiel P
    Gut; 2017 Dec; 66(12):2087-2097. PubMed ID: 27694142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiota and inflammatory bowel diseases.
    Miyoshi J; Chang EB
    Transl Res; 2017 Jan; 179():38-48. PubMed ID: 27371886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating omics: the future of IBD?
    Fiocchi C
    Dig Dis; 2014; 32 Suppl 1():96-102. PubMed ID: 25531360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.
    Stylianou E
    Mol Diagn Ther; 2018 Feb; 22(1):11-23. PubMed ID: 28900867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.
    Aleksandrova K; Romero-Mosquera B; Hernandez V
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28867793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in Search of Precision Medicine in IBD.
    Boyapati RK; Kalla R; Satsangi J; Ho GT
    Am J Gastroenterol; 2016 Dec; 111(12):1682-1690. PubMed ID: 27670602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.